[Oct. 1, 2018 7:00 a.m. ETLife Biosciences LLC, the longevity startup founded by Harvard researcher David Sinclair and funded by WeWork’s Adam Neumann, is ramping up an expansion of its bid to become the world’s largest company dedicated to antiaging drugs.Launched publicly in April, the Cambridge, Mass.- based company has six subsidiaries across four continents. Adding to that, it just acquired Lua Technologies Inc., a health-care communications company, to power Life Biosciences’ research collaboration platform. No financial terms of the acquisition.]
It does not look like he needs a shell company.
- Forums
- ASX - By Stock
- ATH
- Phase1 may demonstrate target engagement
Phase1 may demonstrate target engagement, page-34
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $200 | 66.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 75238609 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4967441 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 75238609 | 0.002 |
23 | 117810099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4967441 | 3 |
0.004 | 132321201 | 25 |
0.005 | 22242406 | 25 |
0.006 | 23031950 | 19 |
0.007 | 47726651 | 22 |
Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |